{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:10:09Z","timestamp":1789002609181,"version":"build-2803163510"},"reference-count":109,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T00:00:00Z","timestamp":1553212800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Myocardial tissue damage that occurs during an ischemic event leads to a spiraling deterioration of cardiac muscle structural and functional integrity. Reperfusion is the only known efficacious strategy and is the most commonly used treatment to reduce injury and prevent remodeling. However, timing is critical, and the procedure is not always feasible for a variety of reasons. The complex molecular basis for cardioprotection has been studied for decades but formulation of a viable therapeutic that can significantly attenuate myocardial injury remains elusive. In this review, we address barriers to the development of a fruitful approach that will substantially improve the prognosis of those suffering from this widespread and largely unmitigated disease. Furthermore, we proffer that ephrinA1, a candidate molecule that satisfies many of the important criteria discussed, possesses robust potential to overcome these hurdles and thus offers protection that surpasses the limitations currently observed.<\/jats:p>","DOI":"10.3390\/ijms20061449","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T06:56:52Z","timestamp":1553497012000},"page":"1449","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Use of Multifactorial Treatments to Address the Challenge of Translating Experimental Myocardial Infarct Reduction Strategies"],"prefix":"10.3390","volume":"20","author":[{"given":"Julie L.","family":"Horton","sequence":"first","affiliation":[{"name":"Burdock Group, 859 Outer Road, Orlando, FL 32814, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3321-9861","authenticated-orcid":false,"given":"Jitka","family":"Virag","sequence":"additional","affiliation":[{"name":"Department of Physiology, Brody School of Medicine, 600 Moye Blvd, East Carolina University, Greenville, NC 27834, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,3,22]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control (2019, February 01). FastStat\u2014Leading Causes of Death. Available online: https:\/\/www.cdc.gov\/nchs\/fastats\/leading-causes-of-death.htm."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.jacc.2018.08.1038","article-title":"Fourth Universal Definition of Myocardial Infarction","volume":"72","author":"Thygesen","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.7812\/TPP\/13-127","article-title":"ECG Diagnosis: ST-Elevation Myocardial Infarction","volume":"18","author":"Hwang","year":"2014","journal-title":"Perm. J."},{"key":"ref_4","unstructured":"World Health Organization (2019, March 08). Cardiovascular Disease-Prevention of Recurrences of Myocardial Infarction and Stroke Study. Available online: https:\/\/www.who.int\/cardiovascular_diseases\/priorities\/secondary_prevention\/country\/en\/index1.html."},{"key":"ref_5","unstructured":"Global Burden of Disease Collaborative Network (2018). Global Burden of Disease Study 2017 (GBD 2017) Results, Institute for Health Metrics and Evaluation (IHME). Available online: http:\/\/ghdx.healthdata.org\/gbd-results-tool."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Benjamin, E.J., Blaha, M.J., Chiuve, S.E., Cushman, M., Das, S.R., Deo, R., De Ferranti, S.D., Floyd, J., Fornage, M., and Gillespie, C. (2017). Heart Disease and Stroke Statistics\u20192017 Update: A Report from the American Heart Association. Circulation.","DOI":"10.1161\/CIR.0000000000000485"},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Benjamin, E.J., Virani, S.S., Callaway, C.W., Chamberlain, A.M., Chang, A.R., Cheng, S., Chiuve, S.E., Cushman, M., Delling, F.N., and Deo, R. (2018). Heart Disease and Stroke Statistics\u20142018 Update: A Report from the American Heart Association. Circulation.","DOI":"10.1161\/CIR.0000000000000558"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0735-1097(01)01711-9","article-title":"CORE Study Investigators. The Relationships of Left Ventricular Ejection Fraction, End-Systolic Volume Index and Infarct Size to Six-month Mortality After Hospital Discharge Following Myocardial Infarction Treated by Thrombolysis","volume":"39","author":"Burns","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Roes, S.D., Kelle, S., Kaandorp, T.A., Kokocinski, T., Poldermans, D., Lamb, H.J., Boersma, E., van der Wall, E.E., Fleck, E., and de Roos, A. (2007). Comparison of Myocardial Infarct Size Assessed with Contrast-Enhanced Magnetic Resonance Imaging and Left Ventricular Function and Volumes to Predict Mortality in Patients with Healed Myocardial Infarction. Am. J. Cardiol.","DOI":"10.1016\/j.amjcard.2007.04.029"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Miura, T., and Miki, T. (2008). Limitation of Myocardial Infarct Size in the Clinical Setting: Current Status and Challenges in Translating Animal Experiments into Clinical Therapy. Basic Res. Cardiol.","DOI":"10.1007\/s00395-008-0743-y"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Koruth, J.S., Lala, A., Pinney, S., Reddy, V.Y., and Dukkipati, S.R. (2017). The Clinical Use of Ivabradine. J. Am. Coll. Cardiol.","DOI":"10.1016\/j.jacc.2017.08.038"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Niccoli, G., Borovac, J.A., Vetrugno, V., Camici, P.G., and Crea, F. (2017). Ivabradine in Acute Coronary Syndromes: Protection Beyond Heart Rate Lowering. Int. J. Cardiol.","DOI":"10.1016\/j.ijcard.2017.02.046"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Priti, K., Ranwa, B.L., Gokhroo, R.K., Kishore, K., Bisht, D.S., and Gupta, S. (2017). Ivabradine vs. Metoprolol in Patients with Acute Inferior Wall Myocardial Infarction-\u201cExpanding Arena for Ivabradine\u201d. Cardiovasc. Ther.","DOI":"10.1111\/1755-5922.12266"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Zhang, R.L., Christensen, L.P., and Tomanek, R.J. (2010). Chronic Heart Rate Reduction Facilitates Cardiomyocyte Survival After Myocardial Infarction. Anat. Rec. (Hoboken).","DOI":"10.1002\/ar.21081"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"O\u2019Connor, D.M., Smith, R.S., Piras, B.A., Beyers, R.J., Lin, D., Hossack, J.A., and French, B.A. (2016). Heart Rate Reduction with Ivabradine Protects Against Left Ventricular Remodeling by Attenuating Infarct Expansion and Preserving Remote-Zone Contractile Function and Synchrony in a Mouse Model of Reperfused Myocardial Infarction. J. Am. Heart Assoc.","DOI":"10.1161\/JAHA.115.002989"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"D\u2019Amario, D., Leone, A.M., Borovac, J.A., Cannata, F., Siracusano, A., Niccoli, G., and Crea, F. (2018). Granulocyte Colony-Stimulating Factor for the Treatment of Cardiovascular Diseases: An Update with a Critical Appraisal. Pharmacol. Res.","DOI":"10.1016\/j.phrs.2017.06.001"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Huang, R., Lv, H., Yao, K., Ge, L., Ye, Z., Ding, H., Zhang, Y., Lu, H., Huang, Z., and Zhang, S. (2018). Effects of Different Doses of Granulocyte Colony-Stimulating Factor Mobilization Therapy on Ischemic Cardiomyopathy. Sci. Rep.","DOI":"10.1038\/s41598-018-24020-y"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Pourtaji, A., Jahani, V., Moallem, S.M.H., Karimani, A., and Mohammadpour, A.H. (2018). Application of G-CSF in congestive heart failure treatment. Curr. Cardiol. Rev.","DOI":"10.2174\/1573403X14666181031115118"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ibanez, B., Macaya, C., S\u00e1nchez-Brunete, V., Pizarro, G., Fern\u00e1ndez-Friera, L., Mateos, A., Fern\u00e1ndez-Ortiz, A., Garc\u00eda-Ruiz, J.M., Garc\u00eda-\u00c1lvarez, A., and I\u00f1iguez, A. (2013). Effect of Early Metoprolol on Infarct Size in ST-segment-elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: The Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) Trial. Circulation.","DOI":"10.1161\/CIRCULATIONAHA.113.003653"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Prieto, J., Villena-Guti\u00e9rrez, R., G\u00f3mez, M., Bernardo, E., Pun-Garc\u00eda, A., Garc\u00eda-Lunar, I., Crainiciuc, G., Fern\u00e1ndez-Jim\u00e9nez, R., Sreeramkumar, V., and Bourio-Mart\u00ednez, R. (2017). Neutrophil Stunning by Metoprolol Reduces Infarct Size. Nat. Commun.","DOI":"10.1038\/ncomms14780"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Riedle, N., Dickhaus, H., Erbacher, M., Steen, H., Andrassy, M., Lossnitzer, D., Hardt, S., Rottbauer, W., Zugck, C., and Giannitsis, E. (2010). Early Assessment of Infarct Size and Prediction of Functional Recovery by Quantitative Myocardial Blush Grade in Patients with Acute Coronary Syndromes Treated According to Current Guidelines. Catheter. Cardiovasc. Interv.","DOI":"10.1002\/ccd.22540"},{"key":"ref_22","unstructured":"Ibanez, B., James, S., Agewall, S., Antunes, M.J., Bucciarelli-Ducci, C., Bueno, H., Caforio, A.L.P., Crea, F., Goudevenos, J.A., and Halvorsen, S. (2017). 2017 ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation: The Task Force for the Management of Acute Myocardial Infarction in Patients Presenting with ST-segment Elevation of the European Society of Cardiology (ESC). Eur. Heart J."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"DuSablon, A., Parks, J., Whitehurst, K., Estes, H., Chase, R., Vlahos, E., Sharma, U., Wert, D., and Virag, J. (2017). EphrinA1-Fc Attenuates Myocardial Ischemia\/Reperfusion Injury in Mice. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0189307"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Baron, T., Hambraeus, K., Sundstr\u00f6m, J., Erlinge, D., Jernberg, T., and Lindahl, B. (2015). Type 2 Myocardial Infarction in Clinical Practice. Heart.","DOI":"10.1136\/heartjnl-2014-306093"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jacc.2018.09.086","article-title":"Multitarget Strategies to Reduce Myocardial Ischemia\/Reperfusion Injury: JACC Review Topic of the Week","volume":"73","author":"Davidson","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Heusch, G., and Gersh, B.J. (2017). The Pathophysiology of Acute Myocardial Infarction and Strategies of Protection beyond Reperfusion: A Continual Challenge. Eur. Heart J.","DOI":"10.1093\/eurheartj\/ehw224"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia\/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote Conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Fanaroff, A.C., Morrow, V., Krucoff, M.W., Seltzer, J.H., Perin, E.C., Taylor, D.A., Miller, L.W., Zeiher, A.M., Fern\u00e1ndez-Avil\u00e9s, F., and Losordo, D.W. (2018). A Path Forward for Regenerative Medicine. Circ. Res.","DOI":"10.1161\/CIRCRESAHA.118.313261"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Heusch, G. (2017). Critical Issues for the Translation of Cardioprotection. Circ. Res.","DOI":"10.1161\/CIRCRESAHA.117.310820"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Bulluck, H., Yellon, D.M., and Hausenloy, D.J. (2016). Reducing Myocardial Infarct Size: Challenges and Future Opportunities. Heart.","DOI":"10.1136\/heartjnl-2015-307855"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Jang, W.J., Yang, J.H., Song, Y., Hahn, J.-Y., Chun, W.J., Oh, J.H., Kim, W.S., Lee, Y.T., Yu, C.W., and Lee, H.J. (2019). Second-Generation Drug-Eluting Stenting versus Coronary Artery Bypass Grafting for Treatment of Coronary Chronic Total Occlusion. J. Cardiol.","DOI":"10.1016\/j.jjcc.2018.12.008"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mohr, F.W., Morice, M.C., Kappetein, A.P., Feldman, T.E., St\u00e5hle, E., Colombo, A., Mack, M.J., Holmes, D.R., Morel, M.A., and Van Dyck, N. (2013). Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients with Three-Vessel Disease and Left Main Coronary Disease: 5-year Follow-up of the Randomised, Clinical SYNTAX Trial. Lancet.","DOI":"10.1016\/S0140-6736(13)60141-5"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Kim, Y.G., Park, D.W., Lee, W.S., Park, G.M., Sun, B.J., Lee, C.H., Hwang, K.W., Cho, S.W., Kim, Y.R., and Song, H.G. (2012). Influence of Diabetes Mellitus on Long-Term (Five-Year) Outcomes of Drug-Eluting Stents and Coronary Artery Bypass Grafting for Multivessel Coronary Revascularization. Am. J. Cardiol.","DOI":"10.1016\/j.amjcard.2012.01.377"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0021-9258(18)63427-1","article-title":"Control of Citric Acid Cycle Activity in Rat Heart Mitochondria","volume":"245","author":"LaNoue","year":"1970","journal-title":"J. Biol. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Taegtmeyer, H., and Overturf, M.L. (1988). Effects of Moderate Hypertension on Cardiac Function and Metabolism in the Rabbit. Hypertension.","DOI":"10.1161\/01.HYP.11.5.416"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Sack, M.N., Rader, T.A., Park, S., Bastin, J., McCune, S.A., and Kelly, D.P. (1996). Fatty Acid Oxidation Enzyme Gene Expression Is Downregulated in the Failing Heart. Circulation.","DOI":"10.1161\/01.CIR.94.11.2837"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Aubert, G., Martin, O.J., Horton, J.L., Lai, L., Vega, R.B., Leone, T.C., Koves, T., Gardell, S.J., Kr\u00fcger, M., and Hoppel, C.L. (2016). The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation.","DOI":"10.1161\/CIRCULATIONAHA.115.017355"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Horton, J.L., Davidson, M.T., Kurishima, C., Vega, R.B., Powers, J.C., Matsuura, T.R., Petucci, C., Lewandowski, E.D., Crawford, P.A., and Muoio, D.M. (2019). The Failing Heart Utilizes 3-Hydroxybutyrate as a Metabolic Stress Defense. JCI Insight.","DOI":"10.1172\/jci.insight.124079"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"MacLellan, W.R., and Schneider, M.D. (1997). Death by Design: Programmed Cell Death in Cardiovascular Biology and Disease. Circ. Res.","DOI":"10.1161\/01.RES.81.2.137"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Freude, B., Masters, T.N., Kostin, S., Robicsek, F., and Schaper, J. (1998). Cardiomyocyte Apoptosis in Acute and Chronic Conditions. Basic Res. Cardiol.","DOI":"10.1007\/s003950050066"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Dries, J.L., Kent, S.D., and Virag, J.A.I. (2011). Intramyocardial Administration of Chimeric EphrinA1-Fc Promotes Tissue Salvage Following Myocardial Infarction in Mice. J. Physiol.","DOI":"10.1113\/jphysiol.2010.202366"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Nakai, A., Yamaguchi, O., Takeda, T., Higuchi, Y., Hikoso, S., Taniike, M., Omiya, S., Mizote, I., Matsumura, Y., and Asahi, M. (2007). The Role of Autophagy in Cardiomyocytes in the Basal State and in Response to Hemodynamic Stress. Nat. Med.","DOI":"10.1038\/nm1574"},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Dorn, G.W., and Diwan, A. (2008). The Rationale for Cardiomyocyte Resuscitation in Myocardial Salvage. J. Mol. Med.","DOI":"10.1007\/s00109-008-0362-y"},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Porrello, E.R., and Delbridge, L.M.D. (2009). Cardiomyocyte Autophagy Is Regulated by Angiotensin II Type 1 and Type 2 Receptors. Autophagy.","DOI":"10.4161\/auto.5.8.10153"},{"key":"ref_45","unstructured":"Fishbein, M.C., Maclean, D., and Maroko, P.R. (1978). Experimental Myocardial Infarction in the Rat: Qualitative and Quantitative Changes during Pathologic Evolution. Am. J. Pathol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Frangogiannis, N.G., Smith, C.W., and Entman, M.L. (2002). The Inflammatory Response in Myocardial Infarction. Cardiovasc. Res.","DOI":"10.1016\/S0008-6363(01)00434-5"},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Virag, J.I., and Murry, C.E. (2003). Myofibroblast and Endothelial Cell Proliferation during Murine Myocardial Infarct Repair. Am. J. Pathol.","DOI":"10.1016\/S0002-9440(10)63598-5"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.trsl.2009.07.010","article-title":"Pharmacogenetic Profiling in the Treatment of Heart Disease","volume":"154","author":"Dorn","year":"2009","journal-title":"Transl. Res."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Frangogiannis, N.G. (2008). The Immune System and Cardiac Repair. Pharmacol. Res.","DOI":"10.1016\/j.phrs.2008.06.007"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lambert, J.M., Lopez, E.F., and Lindsey, M.L. (2008). Macrophage Roles Following Myocardial Infarction. Int. J. Cardiol.","DOI":"10.1016\/j.ijcard.2008.04.059"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Nah, D.Y., and Rhee, M.Y. (2009). The Inflammatory Response and Cardiac Repair after Myocardial Infarction. Korean Circ. J.","DOI":"10.4070\/kcj.2009.39.10.393"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Frangogiannis, N.G. (2017). Fibroblasts and the Extracellular Matrix in Right Ventricular Disease. Cardiovasc. Res.","DOI":"10.1093\/cvr\/cvx146"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Wells, J.M., Gaggar, A., and Blalock, J.E. (2015). MMP Generated Matrikines. Matrix Biol.","DOI":"10.1016\/j.matbio.2015.01.016"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Turner, N.A. (2016). Inflammatory and Fibrotic Responses of Cardiac Fibroblasts to Myocardial Damage Associated Molecular Patterns (DAMPs). J. Mol. Cell Cardiol.","DOI":"10.1016\/j.yjmcc.2015.11.002"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Prabhu, S.D., and Frangogiannis, N.G. (2016). The Biological Basis for Cardiac Repair after Myocardial Infarction. Circ. Res.","DOI":"10.1161\/CIRCRESAHA.116.303577"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Shinde, A.V., Humeres, C., and Frangogiannis, N.G. (2017). The Role of \u03b1-Smooth Muscle Actin in Fibroblast-Mediated Matrix Contraction and Remodeling. Biochim. Biophys. Acta Mol. Basis Dis.","DOI":"10.1016\/j.bbadis.2016.11.006"},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Ong, S.B., Katwadi, K., Kwek, X.Y., Ismail, N.I., Chinda, K., Ong, S.G., and Hausenloy, D.J. (2018). Non-Coding RNAs as Therapeutic Targets for Preventing Myocardial Ischemia-Reperfusion Injury. Expert Opin. Ther. Targets.","DOI":"10.1080\/14728222.2018.1439015"},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"French, B.A., and Holmes, J.W. (2019). Implications of Scar Structure and Mechanics for Post-Infarction Cardiac Repair and Regeneration. Exp. Cell Res.","DOI":"10.1016\/j.yexcr.2019.01.001"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wenk, J.F., Klepach, D., Lee, L.C., Zhang, Z., Ge, L., Tseng, E.E., Martin, A., Kozerke, S., Gorman, J.H., and Gorman, R.C. (2012). First Evidence of Depressed Contractility in the Border Zone of a Human Myocardial Infarction. Ann. Thorac. Surg.","DOI":"10.1016\/j.athoracsur.2011.12.066"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Pfeffer, M.A., and Braunwald, E. (1991). Ventricular Enlargement Following Infarction Is a Modifiable Process. Am. J. Cardiol.","DOI":"10.1016\/0002-9149(91)90270-U"},{"key":"ref_61","doi-asserted-by":"crossref","unstructured":"Gaudron, P., Eilles, C., Kugler, I., and Ertl, G. (1993). Progressive Left Ventricular Dysfunction and Remodeling after Myocardial Infarction. Potential Mechanisms and Early Predictors. Circulation.","DOI":"10.1161\/01.CIR.87.3.755"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/S0733-8651(05)70039-4","article-title":"Ventricular Remodeling. Mechanisms and Prevention","volume":"16","author":"Goldstein","year":"1998","journal-title":"Cardiol. Clin."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Holmes, J.W., Borg, T.K., and Covell, J.W. (2005). Structure and Mechanics of Healing Myocardial Infarcts. Annu. Rev. Biomed. Eng.","DOI":"10.1146\/annurev.bioeng.7.060804.100453"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Cirillo, M., and Arpesella, G. (2008). Rewind the Heart: A Novel Technique to Reset Heart Fibers\u2019 Orientation in Surgery for Ischemic Cardiomyopathy. Med. Hypotheses.","DOI":"10.1016\/j.mehy.2007.07.047"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1093\/clinchem\/41.12.1710","article-title":"Cardiac Troponin-I Is Not Expressed in Fetal and Healthy or Diseased Adult Human Skeletal Muscle Tissue","volume":"41","author":"Bodor","year":"1995","journal-title":"Clin. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1515\/CCLM.1999.002","article-title":"Cardiac Troponin I and Troponin T: Recent Players in the Field of Myocardial Markers","volume":"37","author":"Chapelle","year":"1999","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1161\/01.CIR.0000037106.76139.53","article-title":"ACC\/AHA Guideline Update for the Management of Patients with Unstable Angina and Non-ST-Segment Elevation Myocardial Infarction\u20142002: Summary Article: A Report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)","volume":"106","author":"Braunwald","year":"2002","journal-title":"Circulation"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0167-5273(03)00105-0","article-title":"Cardiac Troponin T and I and Creatine Kinase-MB as Markers of Myocardial Injury and Predictors of Outcome Following Percutaneous Coronary Intervention","volume":"92","author":"Nageh","year":"2003","journal-title":"Int. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Oyama, M.A., and Sisson, D.D. (2004). Cardiac Troponin-I Concentration in Dogs with Cardiac Disease. J. Vet. Intern. Med.","DOI":"10.1892\/0891-6640(2004)18<831:CTCIDW>2.0.CO;2"},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Jaffe, A.S. (2005). Use of Biomarkers in the Emergency Department and Chest Pain Unit. Cardiol. Clin.","DOI":"10.1016\/j.ccl.2005.08.013"},{"key":"ref_71","unstructured":"Ranya, N., and Sweis, A.J. (2019, February 03). Acute Myocardial Infarction (MI). Available online: https:\/\/www.merckmanuals.com\/professional\/cardiovascular-disorders\/coronary-artery-disease\/acute-myocardial-infarction-mi#v27852674."},{"key":"ref_72","doi-asserted-by":"crossref","unstructured":"M\u00e5nsson-Broberg, A., Siddiqui, A.J., Genander, M., Grinnemo, K.H., Hao, X., Andersson, A.B., W\u00e4rdell, E., Sylv\u00e9n, C., and Corbascio, M. (2008). Modulation of EphrinB2 Leads to Increased Angiogenesis in Ischemic Myocardium and Endothelial Cell Proliferation. Biochem. Biophys. Res. Commun.","DOI":"10.1016\/j.bbrc.2008.06.036"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Hirai, H., Maru, Y., Hagiwara, K., Nishida, J., and Takaku, F. (1987). A Novel Putative Tyrosine Kinase Receptor Encoded by the Eph Gene. Science.","DOI":"10.1126\/science.2825356"},{"key":"ref_74","doi-asserted-by":"crossref","unstructured":"Br\u00fcckner, K., Pasquale, E.B., and Klein, R. (1997). Tyrosine Phosphorylation of Transmembrane Ligands for Eph Receptors. Science.","DOI":"10.1126\/science.275.5306.1640"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Mellitzer, G., Xu, Q., and Wilkinson, D.G. (1999). Eph Receptors and Ephrins Restrict Cell Intermingling and Communication. Nature.","DOI":"10.1038\/21907"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Klein, R. (2001). Excitatory Eph Receptors and Adhesive Ephrin Ligands. Curr. Opin. Cell Biol.","DOI":"10.1016\/S0955-0674(00)00197-6"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Kullander, K., and Klein, R. (2002). Mechanisms and Functions of Eph and Ephrin Signalling. Nat. Rev. Mol. Cell Biol.","DOI":"10.1038\/nrm856"},{"key":"ref_78","doi-asserted-by":"crossref","unstructured":"Pasquale, E.B. (2008). Eph-Ephrin Bidirectional Signaling in Physiology and Disease. Cell.","DOI":"10.1016\/j.cell.2008.03.011"},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Pasquale, E.B. (2010). Eph Receptors and Ephrins in Cancer: Bidirectional Signalling and Beyond. Nat. Rev. Cancer.","DOI":"10.1038\/nrc2806"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Zhou, R. (1998). The Eph Family Receptors and Ligands. Pharmacol. Ther.","DOI":"10.1016\/S0163-7258(97)00112-5"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Arvanitis, D., and Davy, A. (2008). Eph\/Ephrin Signaling: Networks. Genes Dev.","DOI":"10.1101\/gad.1630408"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/376037a0","article-title":"Identification and Inhibition of the ICE\/CED-3 Protease Necessary for Mammalian Apoptosis","volume":"376","author":"Nicholson","year":"1995","journal-title":"Nature"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0092-8674(95)90541-3","article-title":"Yama\/CPP32 Beta, a Mammalian Homolog of CED-3, Is a CrmA-Inhibitable Protease That Cleaves the Death Substrate Poly(ADP-Ribose) Polymerase","volume":"81","author":"Tewari","year":"1995","journal-title":"Cell"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"33533","DOI":"10.1074\/jbc.273.50.33533","article-title":"Importance of Poly(ADP-Ribose) Polymerase and Its Cleavage in Apoptosis. Lesson from an Uncleavable Mutant","volume":"273","author":"Oliver","year":"1998","journal-title":"J. Biol. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3835(02)00456-1","article-title":"What\u2019s in the \u201cBAG\u201d?\u2014A Functional Domain Analysis of the BAG-Family Proteins","volume":"188","author":"Doong","year":"2002","journal-title":"Cancer Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"20723","DOI":"10.1074\/jbc.M400399200","article-title":"BAG-1 Proteins Protect Cardiac Myocytes from Simulated Ischemia\/Reperfusion-Induced Apoptosis via an Alternate Mechanism of Cell Survival Independent of the Proteasome","volume":"279","author":"Townsend","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yjmcc.2004.11.005","article-title":"Convergent Signal Transduction Pathways Controlling Cardiomyocyte Survival and Function: The Role of PI 3-Kinase and Akt","volume":"38","author":"Matsui","year":"2005","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1302.021","article-title":"Regulation of Cell Size and Contractile Function by AKT in Cardiomyocytes","volume":"1015","author":"Latronico","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.cardiores.2006.01.017","article-title":"Survival Kinases in Ischemic Preconditioning and Postconditioning","volume":"70","author":"Hausenloy","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10863-009-9205-y","article-title":"Akt Mediated Mitochondrial Protection in the Heart: Metabolic and Survival Pathways to the Rescue","volume":"41","author":"Miyamoto","year":"2009","journal-title":"J. Bioenerg. Biomembr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4161\/auto.7.4.14395","article-title":"Acute Induction of Autophagy as a Novel Strategy for Cardioprotection: Getting to the Heart of the Matter","volume":"7","author":"Przyklenk","year":"2011","journal-title":"Autophagy"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0076-6879(08)04016-0","article-title":"Chapter 16 Novel Methods for Measuring Cardiac Autophagy In Vivo","volume":"453","author":"Perry","year":"2009","journal-title":"Methods Enzymol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.yjmcc.2008.01.010","article-title":"Recycle or Die: The Role of Autophagy in Cardioprotection","volume":"44","author":"Gustafsson","year":"2008","journal-title":"J. Mol. Cell. Cardiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11596-015-1381-x","article-title":"Rapamycin Protects Cardiomyocytes against Anoxia\/Reoxygenation Injury by Inducing Autophagy through the PI3k\/Akt Pathway","volume":"35","author":"Wang","year":"2015","journal-title":"J. Huazhong Univ. Sci. Technol. Med. Sci."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0076-6879(08)03613-6","article-title":"Chapter 13 Cytosolic LC3 Ratio as a Quantitative Index of Macroautophagy","volume":"452","author":"Kadowaki","year":"2009","journal-title":"Methods Enzymol."},{"key":"ref_96","doi-asserted-by":"crossref","unstructured":"Pandey, A., Shao, H., Marks, R.M., Polverini, P.J., and Dixit, V.M. (1995). Role of B61, the Ligand for the Eck Receptor Tyrosine Kinase, in TNF-\u03b1-Induced Angiogenesis. Science.","DOI":"10.1126\/science.7536959"},{"key":"ref_97","doi-asserted-by":"crossref","unstructured":"Cheng, N., Brantley, D.M., and Chen, J. (2002). The Ephrins and Eph Receptors in Angiogenesis. Cytokine Growth Factor Rev.","DOI":"10.1016\/S1359-6101(01)00031-4"},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Moon, J.J., Lee, S.H., and West, J.L. (2007). Synthetic Biomimetic Hydrogels Incorporated with Ephrin-A1 for Therapeutic Angiogenesis. Biomacromolecules.","DOI":"10.1021\/bm060452p"},{"key":"ref_99","doi-asserted-by":"crossref","unstructured":"Ogawa, K., Pasqualini, R., Lindberg, R.A., Kain, R., Freeman, A.L., and Pasquale, E.B. (2000). The Ephrin-A1 Ligand and Its Receptor, EphA2, Are Expressed during Tumor Neovascularization. Oncogene.","DOI":"10.1038\/sj.onc.1204004"},{"key":"ref_100","doi-asserted-by":"crossref","unstructured":"Brantley-Sieders, D.M., Fang, W.B., Hwang, Y., Hicks, D., and Chen, J. (2006). Ephrin-A1 Facilitates Mammary Tumor Metastasis through an Angiogenesis-Dependent Mechanism Mediated by EphA Receptor and Vascular Endothelial Growth Factor in Mice. Cancer Res.","DOI":"10.1158\/0008-5472.CAN-06-1560"},{"key":"ref_101","doi-asserted-by":"crossref","unstructured":"Wykosky, J., Palma, E., Gibo, D.M., Ringler, S., Turner, C.P., and Debinski, W. (2008). Soluble Monomeric EphrinA1 Is Released from Tumor Cells and Is a Functional Ligand for the EphA2 Receptor. Oncogene.","DOI":"10.1038\/onc.2008.328"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Shaut, C.A., Saneyoshi, C., Morgan, E.A., Knosp, W.M., Sexton, D.R., and Stadler, H.S. (2007). HOXA13 Directly Regulates EphA6 and EphA7 Expression in the Genital Tubercle Vascular Endothelia. Dev. Dyn.","DOI":"10.1002\/dvdy.21077"},{"key":"ref_103","doi-asserted-by":"crossref","unstructured":"Ivanov, A., and Romanovsky, A. (2006). Putative Dual Role of Ephrin-Eph Receptor Interactions in Inflammation. IUBMB Life.","DOI":"10.1080\/15216540600756004"},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Lefer, D.J., and Bolli, R. (2011). Development of an NIH Consortium for PreclinicAl AssESsment of CARdioprotective Therapies (CAESAR): A Paradigm Shift in Studies of Infarct Size Limitation. J. Cardiovasc. Pharmacol. Ther.","DOI":"10.1177\/1074248411414155"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.mehy.2013.02.024","article-title":"Ephrin\u2013Eph Signaling as a Potential Therapeutic Target for the Treatment of Myocardial Infarction","volume":"80","author":"Griffin","year":"2013","journal-title":"Med. Hypotheses"},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Spath, N.B., Mills, N.L., and Cruden, N.L. (2016). Novel Cardioprotective and Regenerative Therapies in Acute Myocardial Infarction: A Review of Recent and Ongoing Clinical Trials. Future Cardiol.","DOI":"10.2217\/fca-2016-0044"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Kloner, R.A. (2013). Current State of Clinical Translation of Cardioprotective Agents for Acute Myocardial Infarction. Circ. Res.","DOI":"10.1161\/CIRCRESAHA.112.300627"},{"key":"ref_108","first-page":"351","article-title":"Combination Therapy for Maximal Myocardial Infarct Size Reduction","volume":"3","author":"Hale","year":"2010","journal-title":"Heart Dis."},{"key":"ref_109","first-page":"2","article-title":"Reducing Myocardial Infarct Size: Myth or Reality?","volume":"70","author":"Marzilli","year":"2016","journal-title":"Heart Metab."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/6\/1449\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:39:51Z","timestamp":1760186391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/20\/6\/1449"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,22]]},"references-count":109,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,3]]}},"alternative-id":["ijms20061449"],"URL":"https:\/\/doi.org\/10.3390\/ijms20061449","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,22]]}}}